Stockreport

MEI Pharma and Beigene collaborates to evaluate ME-401 in combination with zanubrutinib in patients with b-cell malignancies [Seeking Alpha]

MEI Pharma, Inc.  (MEIP) 
Last mei pharma, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.meipharma.com
PDF MEI Pharma and Beigene collaborates to evaluate ME-401 in combination with zanubrutinib in patients with b-cell malignancies [Read more]